Saurabh Zanwar

1.5k total citations
69 papers, 504 citations indexed

About

Saurabh Zanwar is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Saurabh Zanwar has authored 69 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Oncology and 22 papers in Hematology. Recurrent topics in Saurabh Zanwar's work include Multiple Myeloma Research and Treatments (19 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Histiocytic Disorders and Treatments (12 papers). Saurabh Zanwar is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Histiocytic Disorders and Treatments (12 papers). Saurabh Zanwar collaborates with scholars based in United States, India and Puerto Rico. Saurabh Zanwar's co-authors include Jithma P. Abeykoon, Prashant Kapoor, Shaji Kumar, Bharat Nandakumar, Kumar Prabhash, Vanita Noronha, Amit Joshi, Vijay Patil, Eli Muchtar and Morie A. Gertz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Saurabh Zanwar

62 papers receiving 494 citations

Peers

Saurabh Zanwar

ONCOL

HEMAT

PRM

SURGE

Konstantin Schlick Austria

Tadahiko Igarashi Japan

Anjum Hassan United States

Bhuvana A. Setty United States

Deepti Behl United States

Shilpa Paul United States

Leonard Christopher Schmeel Germany

Isabel Moreno Spain

Yi‐Fang Chang Taiwan

Qi-rong Geng China

Konstantin Schlick Austria

Saurabh Zanwar

255 ×1.1

ONCOL

106 ×0.6

111 ×0.8

HEMAT

83 ×0.8

PRM

56 ×0.7

SURGE

Citations per year, relative to Saurabh Zanwar Saurabh Zanwar (= 1×) peers Konstantin Schlick

Countries citing papers authored by Saurabh Zanwar

Since Specialization

Citations

This map shows the geographic impact of Saurabh Zanwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saurabh Zanwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saurabh Zanwar more than expected).

Fields of papers citing papers by Saurabh Zanwar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saurabh Zanwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saurabh Zanwar. The network helps show where Saurabh Zanwar may publish in the future.

Co-authorship network of co-authors of Saurabh Zanwar

This figure shows the co-authorship network connecting the top 25 collaborators of Saurabh Zanwar. A scholar is included among the top collaborators of Saurabh Zanwar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saurabh Zanwar. Saurabh Zanwar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sawalha, Yazeed, Shayna Sarosiek, Sudip Thapa, et al.. (2025). Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis. Blood Cancer Journal. 15(1). 65–65. 1 indexed citations

Ravindran, Aishwarya, Liuyan Jiang, Gordon Ruan, et al.. (2025). PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasms. Leukemia & lymphoma. 66(14). 2675–2684.

Abeykoon, Jithma P., Saurabh Zanwar, Gordon Ruan, et al.. (2025). Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants. Leukemia. 39(4). 991–994. 3 indexed citations

Zanwar, Saurabh & S. Vincent Rajkumar. (2025). Current risk stratification and staging of multiple myeloma and related clonal plasma cell disorders. Leukemia. 39(11). 2610–2617.

Ho, Matthew, et al.. (2025). Extramedullary Multiple Myeloma: Challenges and Opportunities. Current Oncology. 32(3). 182–182. 1 indexed citations

Bennani, N. Nora, Gaurav Goyal, Aishwarya Ravindran, et al.. (2024). Efficacy of Small Molecule Kinase Inhibitors in Histiocytic Neoplasms with Non-BRAFV600E Mutations: Concordance of Pre-Clinical Predictions to Clinical Responses. Blood. 144(Supplement 1). 4564–4564. 1 indexed citations

Zanwar, Saurabh, Martha M. Howe, Moritz Binder, et al.. (2024). The Mutational Landscape of Extramedullary Multiple Myeloma Reveals Novel Biologic Insights and Potential Therapeutic Targets for Exploration. Blood. 144(Supplement 1). 2744–2744. 1 indexed citations

Ruan, Gordon, Saurabh Zanwar, Aishwarya Ravindran, et al.. (2024). Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis. American Journal of Hematology. 99(5). 871–879. 9 indexed citations

Smith, Katherine E., Surendra Dasari, Wasantha Ranatunga, et al.. (2024). Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations. JCO Precision Oncology. 8(8). e2400471–e2400471. 2 indexed citations

10.

Zanwar, Saurabh & Shaji Kumar. (2024). Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the future. Leukemia & lymphoma. 66(4). 573–583. 2 indexed citations

11.

Zanwar, Saurabh, Eapen K. Jacob, Kevin D. Pavelko, et al.. (2023). The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant. Blood Cancer Journal. 13(1). 151–151. 4 indexed citations

12.

Goyal, Gaurav, Jithma P. Abeykoon, Chen Dai, et al.. (2023). Long-term outcomes among adults with Langerhans cell histiocytosis. Blood Advances. 7(21). 6568–6578. 10 indexed citations

13.

Ravindran, Aishwarya, Surendra Dasari, Gordon Ruan, et al.. (2023). Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells. Modern Pathology. 36(10). 100268–100268. 15 indexed citations

14.

Ho, Matthew, Saurabh Zanwar, Prashant Kapoor, et al.. (2021). The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM). Blood Cancer Journal. 11(9). 158–158. 6 indexed citations

15.

Zanwar, Saurabh, Jithma P. Abeykoon, & Prashant Kapoor. (2019). Current Therapeutic Options in Waldenström Macroglobulinemia. 15(1). 39–39. 2 indexed citations

16.

Ostwal, Vikas, Arvind Sahu, Saurabh Zanwar, et al.. (2018). Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer. The Indian Journal of Medical Research. 148(3). 284–290. 5 indexed citations

17.

Zanwar, Saurabh, Amit Joshi, Vanita Noronha, et al.. (2016). EGFR mutation in squamous cell carcinoma of lung - Does it carry the same connotation as in adenocarcinomas?. Annals of Oncology. 27. vi431–vi431.

18.

Prabhash, Kumar, Saurabh Zanwar, Amit Joshi, et al.. (2016). Patterns of care and outcomes for second-line targeted therapy in metastatic renal cell carcinomas: A registry based analysis. Indian Journal of Cancer. 53(4). 579–579. 4 indexed citations

19.

Zanwar, Saurabh, Vikas Ostwal, Arvind Sahu, et al.. (2016). Rectal GIST—Outcomes and viewpoint from a tertiary cancer center. Indian Journal of Gastroenterology. 35(6). 445–449. 8 indexed citations

20.

Zanwar, Saurabh, Mahesh Goel, Shraddha Patkar, et al.. (2016). A Case of Ruptured Adult Embryonal Sarcoma of the Liver with Excellent Outcome After Neoadjuvant Chemotherapy. Journal of Gastrointestinal Cancer. 48(1). 100–102. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact